72 / 224
786
38. Sweeney AD, Carlson ML, Zuniga MG, Bennett ML, Wanna GB, et
al. Impact of perioperative oral steroid use on low-frequency
hearing preservation after cochlear implantation. Otol
Neurotol. 2015. 36(9), 1480-5.
39. Stathopoulos D, Chambers S, Enke YL, Timbol G, Risi F, et al.
Development of a safe dexamethasone-eluting electrode
array for cochlear implantation. Cochlear Implants Int. 2014.
15(5), 254-63.
40. Lee MY, Lee JH, Lee HS, Choi JJ, Jang J, et al. Continuous topical
drug delivery using osmotic pump in animal cochlear implant
model: Continuous steroid delivery is effective for hearing
preservation. Acta Otolaryngol. 2015. 135(8), 791-8.
41. Simpson A, McDermott HJ, Dowell RC, Sucher C, Briggs RJ.
Comparison of two frequency-to-electrode maps for acoustic-
electric stimulation. Int J Audiol. 2009. 48(2), 63-73.
42. Fitzgerald MB1, Sagi E, Jackson M, Shapiro WH, Roland JT Jr,
et al. Reimplantation of hybrid cochlear implant users with
a full-length electrode after loss of residual hearing. Otol
Neurotol 2008. 29(2), 168–173.
[REV. MED. CLIN. CONDES - 2016; 27(6) 776-786]